SEC Form 4 · accession 0000880771-16-000200
SCICLONE PHARMACEUTICALS INC · SCLN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Wilson Wai-Shun Cheung
Officer — CFO & Senior VP, Finance
Period of report
Oct 25, 2016
Accepted (ET)
Oct 27, 2016 · 1:00 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000880771
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Oct 25, 2016 | S | 70 | $10.00 | D | 15,064 | D | |
| Common Stock | Oct 26, 2016 | S | 15,064 | $10.00 | D | 0 | D | |
| Common Stock | Oct 26, 2016 | M | 45,208 | $4.52 | A | 45,208 | D | |
| Common Stock | Oct 26, 2016 | S | 45,208 | $10.00 | D | 0 | D | |
| Common Stock | Oct 26, 2016 | M | 48,995 | $5.97 | A | 48,995 | D | |
| Common Stock | Oct 26, 2016 | S | 48,995 | $10.00 | D | 0 | D | |
| Common Stock | Oct 26, 2016 | M | 40,625 | $5.97 | A | 40,625 | D | |
| Common Stock | Oct 26, 2016 | S | 40,625 | $10.00 | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F2,F3 | $4.52 | Oct 26, 2016 | M | 45,208 | D | — | Mar 14, 2024 | Common Stock | 45,208 | 24,792 | D |
| Non-Qualified Stock Option (right to buy)F2,F3 | $5.97 | Oct 26, 2016 | M | 40,625 | D | — | Jul 16, 2023 | Common Stock | 40,625 | 9,375 | D |
| Non-Qualified Stock Option (right to buy)F2,F4 | $5.97 | Oct 26, 2016 | M | 48,995 | D | — | Aug 9, 2023 | Common Stock | 48,995 | 0 | D |
Explanation of responses
- F1The reported sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 15, 2016.
- F2Granted under the Issuer's 2005 Equity Incentive Plan.
- F325% of such shares vest from one year from the date of grant and 2.0833% vests each month thereafter, provided that the Reporting Person continues to be employed by the Issuer.
- F4Provided Reporting Person remains employed by Issuer, the options will vest based upon the successful and timely filing by the SEC filing dates of the 10-Q and 10-Ks for the period from September 30, 2013 through the end of 2014, with the last 10-K filed for the year ending December 31, 2014 by March 16, 2015 (the "Performance Target"). If the Performance Target is not achieved, the options will not vest and will expire on March 17, 2015.